Advanced search×

Effects of rituximab therapy on quality of life in patients with primary Sjögren's syndrome.

Clin Exp Rheumatol 29(1):6-12 (2011) PMID 21345287

To assess the efficacy of the anti-CD20 antibody rituximab in improving physical function and health-related quality of life (HRQoL) in patients with active primary Sjögren's syndrome (pSS), as well as the duration and sources of HRQoL improvements.

Version: za2963e q8za5 q8zb0 q8zcf q8zd2 q8ze8 q8zf7 q8zg7

Similar articles you may find interesting…

  1. Gene therapy for the peripheral nervous system: a strategy to repair the injured nerve?

    Curr Gene Ther 11(2):75-89 (2011) PMID 21291360

  2. Antibiotic-impregnated ventriculo-peritoneal shunts in patients at high risk of infection.

    Audio, Transactions of the IRE Profess... 151(10):1259-63 (2009) PMID 19390777

    We believe that in these patients AIS could be effective. Larger, prospective studies are needed in order to definitely address this issue....
  3. Thoracoscopic and Anatomic Landmarks of Kuntz's Nerve: Implications for Sympathetic Surgery

    Ann Thorac Surg 86(5):6 (2008) PMID 19049766

    The low thoracoscopic detection rate of KNs may be due to the low color contrast of these small fibers. They have, however, most frequently concomitant subpleural veins that are easier to detect. These veins may serve as orientation landmarks of KNs and thus contribute to a more complete denervation...